Xencor (XNCR) Change in Cash (2013 - 2026)
Xencor (XNCR) reported Change in Cash of -$40.0 million for Q1 2026, down 2969.92% year-over-year from $1.4 million in Q1 2025, and down 255.14% quarter-over-quarter from $25.8 million in Q4 2025.
Xencor (XNCR) Change in Cash (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Change in Cash data on file, last reported at -$40.0 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$40.0 million, down 2969.92% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.6 million (down 399.64% YoY), and the FY2025 annual result was $13.1 million, up 201.49% from the prior year.
- Change in Cash retreated to -$40.0 million in Q1 2026 per XNCR's latest filing, from $25.8 million in the prior quarter.
- Over five years, Change in Cash peaked at $25.8 million in Q4 2025 and troughed at -$65.2 million in Q1 2022.
- A 5-year average of -$7.6 million and a median of -$264000.0 in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2025 and 2026: Change in Cash soared 1906.44% in 2025, then slumped 2969.92% in 2026.
- A 5-year view of Change in Cash shows it stood at $1.3 million in 2022, then dropped by 17.78% to $1.1 million in 2023, then soared by 1018.6% to $11.8 million in 2024, then surged by 117.65% to $25.8 million in 2025, then sank by 255.14% to -$40.0 million in 2026.
- Business Quant data shows XNCR's Change in Cash at -$40.0 million in Q1 2026, $25.8 million in Q4 2025, and -$16.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.00 Mn |
| Dec 31, 2025 | 25.78 Mn |
| Sep 30, 2025 | -16.15 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | 11.85 Mn |
| Sep 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | -264,000.00 |
| Mar 31, 2024 | -22.75 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 18.40 Mn |
| Jun 30, 2023 | -37.68 Mn |
| Mar 31, 2023 | 18.45 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 3.24 Mn |
| Jun 30, 2022 | -28.86 Mn |
| Mar 31, 2022 | -65.21 Mn |
| Dec 31, 2021 | 102.28 Mn |
| Sep 30, 2021 | -74.64 Mn |
| Jun 30, 2021 | -61.12 Mn |